Literature DB >> 11545246

Competition of IL-1 and IL-1ra determines lymphocyte response to delayed stimulation with PHA.

M P Dabrowski1, W Stankiewicz, T Płusa, A Chciałowski, S Szmigielski.   

Abstract

BACKGROUND: Human peripheral blood mononuclear cells (PBMC) left in microcultures for 24h without mitogen do not respond to subsequent stimulation with PHA. They regain reactivity if the native culture medium is absorbed with other party lymphocytes or partially replaced with the medium from a PHA-stimulated culture. The observations suggest that, during the incubation, some inhibitory agent had accumulated in the culture medium. AIM: The study was performed to determine the nature of the observed phenomenon in respect of the possible role of monocytes and their products IL-1 and IL-1 receptor antagonist (IL-1ra), and to test for immunodiagnostic purposes the significance of quantifying the lymphocyte response to delayed stimulation with PHA in patients suffering from inflammatory prosesses.
METHODS: Lymphocyte response to delayed stimulation with PHA, calculated as the lymphocyte-monokine interaction (LM) index, was determined in the microcultures of PBMC isolated from the blood of healthy donors or of patients with acute tonsilitis. The values of LM indices were compared with the ratios of IL-1ra/IL-1beta concentration estimated by enzyme-linked immunosorbent assay method in the culture supernatants. The influences of exogenous IL-1beta, IL-1ra, anti-IL1ra antibodies and antibiotic cefaclor on the monokine concentrations and on the values of LM index were tested. RESULTS AND
CONCLUSIONS: The results show that the level of lymphocyte response to delayed stimulation with PHA (LM index) is inversely proportional to the ratio of IL-1ra/IL-1beta concentration in the culture. The low LM values at high IL-1ra/IL-1beta ratios in PBMC cultures from healthy donors, reversed proportions found in patients' PBMC (acute tonsilitis), and the cefaclor-induced reduction of LM value with correlated increase of the IL-1ra/IL-1beta ratio suggest that the LM assay may prove to be useful for immunodiagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545246      PMCID: PMC1781706          DOI: 10.1080/09629350124376

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  16 in total

Review 1.  The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.

Authors:  C A Dinarello
Journal:  N Engl J Med       Date:  2000-09-07       Impact factor: 91.245

2.  The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation.

Authors:  N A Mitchison
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

3.  Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF.

Authors:  S B Joseph; K T Miner; M Croft
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

4.  Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors.

Authors:  S B Mizel; J J Farrar
Journal:  Cell Immunol       Date:  1979-12       Impact factor: 4.868

5.  Topical interleukin 1 receptor antagonist promotes corneal transplant survival.

Authors:  M R Dana; J Yamada; J W Streilein
Journal:  Transplantation       Date:  1997-05-27       Impact factor: 4.939

6.  Immunologic and clinical evaluation of multiple sclerosis patients treated with corticosteroids and/or calf thymic hormones.

Authors:  M P Dabrowski; B K Dabrowska-Bernstein; A Stasiak; K Gajkowski; S Korniluk
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

7.  Induction of receptors for interleukin 2 requires T cell Ag:Ia receptor crosslinking and interleukin 1.

Authors:  J Kaye; C A Janeway
Journal:  Lymphokine Res       Date:  1984

Review 8.  Interleukin 1 and T cell activation.

Authors:  S B Mizel
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

9.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist.

Authors:  S P Eisenberg; R J Evans; W P Arend; E Verderber; M T Brewer; C H Hannum; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

10.  A urine inhibitor of interleukin 1 activity that blocks ligand binding.

Authors:  P Seckinger; J W Lowenthal; K Williamson; J M Dayer; H R MacDonald
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

View more
  4 in total

1.  Immunotropic effects in cultured human blood mononuclear cells exposed to a 900 MHz pulse-modulated microwave field.

Authors:  Łukasz Szymański; Elżbieta Sobiczewska; Aleksandra Cios; Pawel Szymanski; Martyna Ciepielak; Wanda Stankiewicz
Journal:  J Radiat Res       Date:  2020-01-23       Impact factor: 2.724

2.  A single step, centrifuge-free method to harvest bone marrow highly concentrated in mesenchymal stem cells: results of a pilot trial.

Authors:  Marco Viganò; Enrico Ragni; Berardo Di Matteo; Francesco Manlio Gambaro; Carlotta Perucca Orfei; Giuseppina Spinelli; Alessandra Colombini; Laura de Girolamo; Elizaveta Kon
Journal:  Int Orthop       Date:  2021-11-02       Impact factor: 3.479

3.  The variances in cytokine production profiles from non- or activated THP-1, Kupffer cell and human blood derived primary macrophages following exposure to either alcohol or a panel of engineered nanomaterials.

Authors:  Ali Kermanizadeh; David M Brown; Vicki Stone
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

4.  Autologous Microfragmented Adipose Tissue Reduces the Catabolic and Fibrosis Response in an In Vitro Model of Tendon Cell Inflammation.

Authors:  Marco Viganò; Gaia Lugano; Carlotta Perucca Orfei; Alessandra Menon; Enrico Ragni; Alessandra Colombini; Paola De Luca; Pietro Randelli; Laura de Girolamo
Journal:  Stem Cells Int       Date:  2019-12-05       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.